« Return to News | CROs/Service Providers

Marken continues expansion with Buenos Aires facility

Tuesday, December 20, 2011 01:39 PM

Marken continues their expansion of services in Latin America, by augmenting their new purpose-built Buenos Aires facility.

"The expansion of our services in Latin America enables our clients to better recruit in treatment naive populations and work with previously unreachable investigator sites, assuring quality and regulatory documentation through the entire supply chain." said Wes Wheeler, Marken's chief executive officer.

Marken is implementing their stated plan to build an advanced, fit for purpose clinical distribution network to serve the pharmaceutical community. The new Argentina depot builds on Marken's current Latin America business which serves over 1200 clinical research investigator sites in the region, and enables the company to grow from its current industry-leading life sciences logistics platform. Marken is developing further depot facilities in Europe, Asia and the Americas.

The Argentina depot joins Marken's already operational Mexico and Singapore depots offering the full range of temperature controlled storage capabilities. Each of Marken's depots provides drug and equipment distribution solutions. Additionally the network manages specimen kit distribution, interim specimen storage and management.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.